Maftivimab Antibody
Maftivimab (REGN3470-3471-3479), also known as Inmazeb, is an FDA-approved monoclonal antibody cocktail targeting the Zaire ebolavirus. It functions as a filovirus inhibitor and is applied in research for studying Ebola virus infection mechanisms, supported by in vitro neutralization and in vivo non-human primate efficacy studies.
Product Specifications
Target
Virus Protease
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9619317-02 5x 1 mg
Phospho-Tuberin/TSC2 (Ser1254) Blocking Peptide
Sign In for Pricing
View Details 
MBS9339352-01 48 Well
Human Breast carcinoma-amplified sequence 1, BCAS1 ELISA Kit
Sign In for Pricing
View Details MBS9339352-02 96 Well
Human Breast carcinoma-amplified sequence 1, BCAS1 ELISA Kit
Sign In for Pricing
View Details MBS9339352-03 5x 96 Well
Human Breast carcinoma-amplified sequence 1, BCAS1 ELISA Kit
Sign In for Pricing
View Details